Literature DB >> 15956402

Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping.

Elena N Ilina1, Maja V Malakhova, Edward V Generozov, Eugene N Nikolaev, Vadim M Govorun.   

Abstract

Determination of the hepatitis C virus (HCV) genotype has become accepted as the standard procedure in laboratory practice. Genotype assignment helps in disease prognosis and assists in establishing the appropriate duration of treatment. More than 10 types and 70 subtypes of HCV have been described. In Russia the most common subtypes are 1a, 1b, 2a, and 3a, and the types 4 and 5 are relatively rare. The "gold standard" for testing is gene sequencing. However, a variety of other assays had been developed to provide more rapid and cheaper forms of testing. The aim of this study was to determine the HCV genotype by minisequencing followed by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Fragments of 5' untranslated region of the HCV genome were amplified. Three oligonucleotide primers were designed to detect two sets of genotype-specific single nucleotide polymorphisms. The primer extension reaction was performed using modified thermostable DNA polymerase and in the presence of dideoxynucleosides. The molecular weights of the reaction products were analyzed with MALDI-TOF mass spectrometer. The HCV genotype was determined by registering the particles of the expected molecular weights. The method was used to genotype HCV from HCV-positive blood sera or plasma. The 1a, 1b, 2a, 3a, and 4 genotype HCVs were determined in the samples examined. The data were confirmed by direct sequencing. Thus, we propose a new accurate and efficient method for HCV genotyping based on minisequencing followed by mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956402      PMCID: PMC1151883          DOI: 10.1128/JCM.43.6.2810-2815.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  MALDI-TOF mass spectrometry-based SNP genotyping.

Authors:  Niels Storm; Brigitte Darnhofer-Patel; Dirk van den Boom; Charles P Rodi
Journal:  Methods Mol Biol       Date:  2003

2.  [Regularities in the spread of hepatitis C virus and its genotypes in Russian and countries within the former USSR].

Authors:  D K L'vov; E I Samokhvalov; S Mishiro; F Tsuda; N A Selivanov; H Okamoto; V M Stakhanova; V L Gromashevskiĭ; V A Aristova; N V Doroshenko; T L Iashina; S N Kuzin; I A Suetina; D S Lobanov; P G Deriabin; L A Ruzaeva; V N Bezgodov; V I Frizen; L A Firsova; L I Firsova; B B Darizhapov; S D L'vov; V N Smirnov; V E Lisitsina; I A Shchukina
Journal:  Vopr Virusol       Date:  1997 Jul-Aug

Review 3.  Factors predictive of a beneficial response to therapy of hepatitis C.

Authors:  G L Davis; J Y Lau
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test.

Authors:  J J Germer; P N Rys; J N Thorvilson; D H Persing
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

Review 5.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes.

Authors:  H Okamoto; K Kurai; S Okada; K Yamamoto; H Lizuka; T Tanaka; S Fukuda; F Tsuda; S Mishiro
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

7.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

Authors:  S W Chan; F McOmish; E C Holmes; B Dow; J F Peutherer; E Follett; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

8.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

Authors:  H Okamoto; Y Sugiyama; S Okada; K Kurai; Y Akahane; Y Sugai; T Tanaka; K Sato; F Tsuda; Y Miyakawa
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

9.  Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region.

Authors:  Frederick S Nolte; Alicia M Green; Kristin R Fiebelkorn; Angela M Caliendo; Cynthia Sturchio; Aileen Grunwald; Mimi Healy
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b.

Authors:  Zhenyu Chen; Karen E Weck
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more
  15 in total

1.  Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Malin I L Sjöholm; Joakim Dillner; Joyce Carlson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

Review 2.  Application of mass spectrometry to molecular diagnostics of viral infections.

Authors:  Lilia M Ganova-Raeva; Yury E Khudyakov
Journal:  Expert Rev Mol Diagn       Date:  2013-05       Impact factor: 5.225

3.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) proteomic profiling of cerebrospinal fluid in the diagnosis of enteroviral meningitis: a proof-of-principle study.

Authors:  Ignacio Torres; Estela Giménez; Víctor Vinuesa; Tania Pascual; Juan Miguel Moya; Juan Alberola; Ana Martínez-Sapiña; David Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-27       Impact factor: 3.267

4.  Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.

Authors:  Elena N Ilina; Vladimir A Vereshchagin; Alexandra D Borovskaya; Maja V Malakhova; Sergei V Sidorenko; Nazar C Al-Khafaji; Anna A Kubanova; Vadim M Govorun
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

5.  Simultaneous detection and identification of enteric viruses by PCR-mass assay.

Authors:  Jingzi Piao; Jun Jiang; Bianli Xu; Xiaohong Wang; Yanfang Guan; Weili Wu; Licheng Liu; Yuan Zhang; Xueyong Huang; Pengzhi Wang; Jinyin Zhao; Xiaoping Kang; Hua Jiang; Yuanyin Cao; Yuling Zheng; Yongqiang Jiang; Yan Li; Yinhui Yang; Weijun Chen
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

6.  Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology.

Authors:  Nader Ghebranious; Lynn Ivacic; Jamie Mallum; Charles Dokken
Journal:  Nucleic Acids Res       Date:  2005-10-04       Impact factor: 16.971

7.  Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.

Authors:  Hubert D-J Daniel; Joel David; Sukanya Raghuraman; Manu Gnanamony; George M Chandy; Gopalan Sridharan; Priya Abraham
Journal:  J Clin Lab Anal       Date:  2016-09-01       Impact factor: 2.352

Review 8.  MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis.

Authors:  Neelja Singhal; Manish Kumar; Pawan K Kanaujia; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2015-08-05       Impact factor: 5.640

9.  Application of maldi-tof mass spectrometry in clinical virology: a review.

Authors:  Fernando Cobo
Journal:  Open Virol J       Date:  2013-09-27

Review 10.  Hepatitis C in the Russian Federation: challenges and future directions.

Authors:  Sergey Mukomolov; Galina Trifonova; Irina Levakova; Daria Bolsun; Eugenia Krivanogova
Journal:  Hepat Med       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.